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Abstract
Background Recently, a number of reports have highlighted
changes in the histopathology and response to corticosteroid
treatment in childhood nephrotic syndrome; however, these
involved ethnically mixed populations. For comparison, the
purpose of our research was to search for changes in the
characteristics of nephrotic syndrome in a homogeneous
population of Caucasian children over two consecutive
decades.
Methods Chart analysis was performed to identify children
with new-onset nephrotic syndrome. The children were
admitted to the Division of Pediatric Nephrology, Zabrze,
during two periods: 1986–1995 (76 patients) and 1996–
2005 (102 patients). Specifically, a comparison of clinical
characteristics and morphology of nephrotic syndrome be-
tween the two groups was performed. Steroid resistance was
defined as no remission within 8 weeks of corticosteroid
treatment. Histopathology was available in 36.8% and
43.1% of patients respectively.
Results There was a significant increase in primary steroid
resistance in the latter decade: 15.8% vs 31.4% (P00.017).
Changes in the histopathology did not reach the level of
statistical significance: minimal change nephrotic syndrome
25% vs 9% (P00.095), mesangial proliferative glomerulo-
nephritis 46.4% vs 61.3% (P00.21), focal segmental
glomerulosclerosis17.9%vs20.4%(P00.78),membranopro-
liferativeglomerulonephritis7.1%vs6.8%(P01.0),membra-
nous glomerulonephritis 3.6% vs 0% (P00.39).
Conclusions Our results show the increasing incidence of
primary steroid resistance in childhood nephrotic syndrome.
Keywords Childhoodnephroticsyndrome.Steroid
resistance.Steroidsensitivity.Minimalchangenephrotic
syndrome.Focalsegmentalglomerulosclerosis
Introduction
Nephrotic syndrome (NS), caused by massive proteinuria,
leading to hypoalbuminemia and edema, seems to be the
most common glomerular pathological condition in child-
hood [1]. Most children who have an NS suffer from idio-
pathic NS with the histopathology of minimal change
glomerulonephritis (MCNS), mesangial proliferative glo-
merulonephritis (MesPGN) or focal segmental glomerulo-
sclerosis (FSGS) [2–4]. Nephrotic syndromes that are
related to the presence of immune complexes in renal tissue
include membranoproliferative glomerulonephritis
(MPGN), membranous glomerulonephritis (MGN), and
others that are rare among children [3, 4]. In the late
1970s, the International Study of Kidney Disease in Chil-
dren (ISKDC) and other single-center studies, reported a
study on renal biopsies in which most children with primary
NS presented with MCNS; other histopathological lesions,
including FSGS, were observed in less than 10% of biopsies
[2, 4–7]. Moreover, steroid sensitivity characterized 93–98%
of the population with MCNS examined and 17–30% of
patients with FSGS, translating into an average response to
corticosteroids 80% of children with primary NS [2, 5–7].
Steroid resistance characterized about 20% of the population
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patients [5–7]. On the basis of the ISKDC report, cortico-
steroids were introduced as a standard treatment of childhood
NS [2, 6, 7].
There is evidence that the characteristics of childhood NS
as described above may be invalid now. A number of reports
were published on changing trends in the histopathology of
NS toward the increasing incidence of FSGS, not only in
adults, but also in children [8–16]. Those changes are ac-
companied by an increase in steroid resistance, as FSGS
seems to be strongly related to poor response to corticoste-
roid therapy. In fact, some reports reveal a significant in-
crease in both primary and secondary steroid resistance in
childhood NS compared with the ISKDC data [17]. How-
ever, these results could have been altered by the racial
composition of populations, as it is widely known that eth-
nicity plays a role in the epidemiology and histopathology of
NS [18–22].
Therefore, the primary objective of our study was to search
for changes in characteristics at onset, patients' response to
treatment, and a histopathological pattern of childhood NS in
a homogeneous population of Caucasian children admitted
with new-onset NS to the Division of Pediatric Nephrology
in Zabrze (southern Poland) over a period of 20 years (1986–
2005).
Materials and methods
Patients
Our approach, based on retrospective chart analysis, was
performed in order to identify all children with new-onset
NS admitted to the Division of Pediatric Nephrology, De-
partment of Pediatrics in Zabrze, Silesian Medical Univer-
sity, between 1986 and 2005. The institution has been a
pediatric nephrology referral center for the region of Silesia
(southern Poland) with about 3,900,000 inhabitants before
1999, and about 4,700,000 inhabitants after the territorial
reorganization of Poland in 1999. The inclusion criteria
comprised:
1. A fulfilled definition of NS
2. Children older than 3 months (to exclude congenital
NS) and under 16 years of age
3. New-onset (and untreated) NS or in the initial stages of
the standard treatment process
4. Primary NS
5. Minimum of 6 months’ follow-up
The exclusion criteria consisted:
1. Non-nephrotic proteinuria
2. Congenital NS
3. NS secondary to metabolic, infectious, vascular, malig-
nant, and cardiac disease
4. Late referrals or already treated NS cases (to avoid
referral and selection bias)
Definitions and treatment
By definition, NS comprises heavy proteinuria exceeding
50 mg/kg/day, hypoalbuminemia <2.5 g/dL, hypercholester-
olemia, and edema. The initial treatment of NS was intro-
duced according to Polish recommendations by Wyszyńska
et al. [23, 24]. All patients received prednisone therapy at a
dose of 60 mg/m
2/day (maximum 80 mg/day) on a daily
basis for the first 4 weeks. In cases of favorable response to
the therapy, administration of prednisone was switched to
60 mg/m
2/every second day and gradually reduced [23]. In
all cases of no response to treatment, either a continuation of
prednisone therapy (in the first examined period: 1986–
1995) or intravenous methylprednisolone pulses (in the
second period examined: 1996–2005) were introduced [24,
25]. The patients’ responses to treatment were assessed by
means of the following definitions: remission—3 consecutive
days of trace or absent proteinuria on the second-morning
urine specimen; steroid sensitivity—remission obtained with-
in 8 weeks of the steroid therapy; with a subgroup of late
responders—remission obtained within the 4th and 8th weeks
of corticosteroid treatment; steroid resistance—no response to
the initial 8-week steroid treatment, with a subgroup of partial
responders—presenting the resolution of edema and a de-
crease in proteinuria. The minimum follow-up of 6 months
was requested and the subsequent steroid response was eval-
uated by means of the following definitions: relapse—3f o l -
lowing days with proteinuria; secondary steroid resistance—
no response to steroids in a primary steroid-sensitive patient;
frequent relapses—two or more episodes of nephrosis within
6 months of the initial response. Blood pressure at presenta-
tion was analyzed as well. Accordingly, hypertension was
defined as systolic blood pressure (SBP) or diastolic blood
pressure (DBP) exceeding the 95th percentile compared with
relevant sex, age, and height percentile levels according to the
fourth report of the National High Blood Pressure Education
Program(NHBPEP)[26].Microscopichematuriawasdefined
as five or more red cells per high-power field in a urine
sediment. The estimated glomerular filtration rate (GFR)
was calculated at the time of presentation according to the
Schwartz formula: GFR0k × height (cm)/plasma creatinine
(mg/dL), where k was equal to 0.45 for infants, 0.55 for older
children and adolescent girls, 0.7 for adolescent boys over
13 years of age [27]. Decreased glomerular filtration was
defined as GFR <90 mL/min/1.73 m
2 (the definition was
adopted from the Kidney Disease Outcomes Quality Initiative
(K/DOQI) guidelines for chronic kidney disease) [28].
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Whenever possible, kidney biopsy was performed with pa-
rental consent, mainly in steroid-resistant children. In
steroid-sensitive children, frequently relapsing NS prior to
the introduction of an alternative treatment (alternative to
corticosteroids), was the main indication for kidney biopsy.
Renal tissues were examined by means of light, immuno-
fluorescence, and electron microscopy. Samples were sub-
ject to interpretation by our pathologist with the presence of
at least five glomeruli. MCNS was described as the absence
of abnormality or a very discreet mesangial matrix expan-
sion on light microscopy. MesPGN was defined as the
presence of mesangial matrix expansion and mesangial
cell proliferation. FSGS was characterized by the pres-
ence of at least one glomerulus with segmental sclerotic
lesions, and MPGN was described as the presence of
mesangial cell proliferation accompanied byimmunedepos-
its along the basement membrane. Finally, MGN was defined
as the presence of immune deposits along the basement
membrane.
Statistical analysis
Continuous data were presented as a median and interquar-
tile range, and statistical significance was analyzed using the
Mann–Whitney U test. For the comparison of contingency
tables the Chi-squared test was used, and in the case of
expected numbers less than five Fisher’s exact test was used.
The statistical significance level was defined as P<0.05
(bilaterally). All statistical analyses were performed using
the Statistica software platform version 7.1 PL (StatSoft,
College Station, TX, USA).
Results
We identified 215 children with new-onset NS that were
admitted to our hospital between 1986 and 2005. The inclu-
sion criteria were met by 178 patients with primary NS. In
order to compare the model of NS in two consecutive
decades, patients included in the study were divided into
two separate groups: Group A—children treated in the first
period of 10 years (1986–1995, n076); Group B—children
treated in the second period (1996–2005, n0102).
Characteristics of childhood NS at presentation
The demographic profile of all patients included in the study
is shown in Table 1. Apparently, there were no statistical age
and sex distribution differences at the onset of NS between
the two groups. Table 2 shows the evidence of symptoms
nonspecific for NS. We found no significant difference in
the frequency of hypertension and decreased GFR at pre-
sentation between the groups. However, we observed an
increased frequency of patients with the presence of micro-
scopic hematuria in the second decade examined.
Response to initial corticosteroid treatment of childhood NS
The initial response to corticosteroid therapy was assessed
after the first 8 weeks of treatment. Based on the data, we
found a statistically significant decrease in the frequency of
steroid sensitivity in the latter decade (Fig. 1). Sixty-two out
of 64 (96.9%) steroid-sensitive patients from Group A, and
62 out of 70 (88.6%) steroid-sensitive patients from Group
B responded to the corticosteroid treatment within the first
4 weeks (P00.1). Only 2 out of 64 children on predni-
sone therapy from Group A (3.1%), and 8 out of 70
children on methylprednisolone pulses from Group B
(11.4%) met the definition of late responders (P00.1).
Three out of 12 steroid-resistant patients from Group A
(25%) and 6 out of 32 steroid-resistant patients from
Group B (18.7%) showed symptoms of partial remission
(P00.69). In the case of a relapse, the initial dose of predni-
sonewasintroducedinsteroid-sensitivepatients.Nostatistical
differenceinthefrequencyofsecondarysteroidresistancewas
found in the population analyzed. In Group A there were 5
secondary steroid-resistant children (6.57%), and in Group B
there were 4 secondary steroid-resistant children (P00.5).
None of the late responders from Group A, and 1 (12.5%)
from Group B became secondary steroid-resistant patients
(P01.0).
Table 1 Age and sex distribution: Group A (1986–1995), Group B
(1996–2005)
Group A Group B P value
(n076) (n0102)
Median age at onset (years) 2.7 3.3 0.072
Interquartile range of
age at onset (years)
2.0–4.1 2.1–6.0 0.072
Male:female ratio 1.2:1 2:1 0.092
Table 2 Clinical and biochemical profile of the presentation: Group A
(1986–1995), Group B (1996–2005). SBP systolic blood pressure;
DBP diastolic blood pressure; GFR glomerular filtration rate
Group A Group B P value
(n076) (n0102)
SBP >95th percentile 37 (48.7%) 41 (40.2%) 0.26
DBP >95th percentile 33 (43.4%) 40 (39.3%) 0.57
GFR <90 mL/min/1.73 m
2 28 (36.8%) 26 (25.5%) 0.1
Microscopic hematuria 21 (27.6%) 50 (49%) 0.004
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Kidney biopsy was performed at a statistically comparable
frequency: in 28 patients of Group A (36.8%) and in 44
patients of Group B (43.1%; P00.4) respectively. Compar-
ing Group A and Group B, we found a slight, statistically
insignificant change in the histopathology of primary NS
toward a decrease in MCNS and an increase in both
MesPGN and FSGS in the more recent decade (Table 3).
Kidney biopsies in steroid-sensitive patients were usually
performed later than in steroid-resistant patients. Therefore,
we additionally compared the morphology of primary
steroid-resistant children biopsied in a comparable early
phase of NS. In the population of steroid-resistant children
kidney biopsy was performed in 9 children from Group A
(75%) and in 25 children from Group B (78.1%; P01.0).
The histopathology of steroid-resistant NS slightly changed
towards the increased incidence of FSGS in the most recent
decade; however, it did not reach the level of statistical
significance (Table 4).
Discussion
Childhood NS used to be considered a benign disease that
was responsive to corticosteroid therapy, mostly with the
morphology of minimal change glomerulonephritis and had
a good long-term prognosis [2, 4, 6, 7]. New evidence,
however, in recent years, suggests that both the histopathol-
ogy and the response to therapy for childhood NS might
have changed [8, 10–14, 16, 17]. Therefore, the purpose of
our study was to explore trends in the clinical and histo-
pathological characteristics of primary NS in Caucasian
children admitted to a pediatric nephrology center in southern
Poland within the two following decades (1986–1995, 76
children; 1996–2005, 102 children). The increase in the num-
ber of children with new-onset NS, treated in the second
period examined (1996–2005) can be explained by the in-
crease in the number of inhabitants in the referral area. This
changed from 3,900,000 before 1999 to 4,700,000 after 1999
owing to the territorial reorganization of Poland. To avoid a
referral bias (as the clinic is a referral pediatric nephrology
center for the region of Silesia), only children with new-onset
untreated NS or children in the very early stages of the
treatment process were included in the analysis. The clinical
characteristics at presentation did not vary significantly. The
high level of incidence of hypertension and decreased renal
function could be explained by transient disturbances in fluid
balance.
To summarize, one major finding of our study was the
discovery of a decreasing rate of steroid sensitivity among
patients with primary NS in the latter period. Steroid sensi-
tivity characterized 84.2% of patients in Group A (1986–
1995). This result was comparable to the corresponding
outcome of the ISKDC report (78%) [2, 7]. However, in
Group B (1996–2005) steroid sensitivity effects were
P=0.017
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Fig. 1 Response to the initial corticosteroid treatment: Group A
(1986–1995), Group B (1996–2005)
Table 3 Histopathology distribution on kidney biopsy: Group A
(1986–1995), Group B (1996–2005). MCNS minimal change nephrotic
syndrome; MesPGN mesangial proliferative glomerulonephritis; FSGS
focal segmental glomerulosclerosis; MPGN membranoproliferative
glomerulonephritis; MGN membranous glomerulonephritis
Group A Group B P value
(n028) (n044)
MCNS 7 (25%) 4 (9%) 0.0095
MesPGN 13 (46.4%) 27 (61.4%) 0.21
FSGS 5 (17.9%) 9 (20.4%) 0.78
MPGN 2 (7.1%) 3 (6.8%) 1
MGN 1 (3.6%) 0 (0%) 0.39
Table 4 H i s t o p a t h o l o g yd i s t r i b u t i o no nk i d n e yb i o p s yi np r i m a r y
steroid-resistant children: Group A (1986–1995), Group B (1996–
2005). MCNS- minimal change nephrotic syndrome, MesPGN- mesan-
gial proliferative glomerulonephritis, FSGS- focal segmental glomerulo-
sclerosis, MPGN- membranoproliferative glomerulonephritis)
Group A Group B P value
(n09) (n025)
MCNS 1 (11%) 1 (4%) 0.47
MesPGN 5 (55.6%) 14 (56%) 1
FSGS 2 (22.2%) 9 (36%) 0.68
MPGN 1 (11.1%) 1 (4%) 0.47
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a significantly lower result. The majority of steroid-sensitive
patients entered remission within the first 4 weeks of daily
prednisone therapy. The continuation of prednisone therapy
over a period of 4 weeks led to remission in 2 patients from
the first decade examined, whereas the introduction of meth-
ylprednisolone pulses resulted in remission in 8 children
from the second decade examined. Evaluating the effects
of steroid therapy in childhood NS is rather strict—patients
can be either steroid-sensitive or steroid-resistant. However,
some authors propose the introduction of the definition of a
partial response to the treatment. In our study, we observed a
minor, but not statistically significant, increase in the num-
ber of partial responders. All of them, despite partial clinical
and biochemical improvement, were classified and further
treated as steroid-resistant patients. Indicating the increase
in steroid resistance in childhood NS, the main finding of
our study seems to be consistent with the results of other
researchers. For example, Kim et al. [17] described steroid
sensitivity in primary NS in only 71% of children admitted
over the period 1994–2003 to two major centers in New
Orleans, which is lower than in the ISKDC study. Moreover,
Kim et al. reported a high incidence (16.5%) of late steroid
resistance compared with the ISKDC study (3.3%) and our
own observations (6.57% and 3.93%). Both Kim et al.’s
study and our analysis showed an inclination toward in-
creasing rates of steroid resistance in childhood NS. How-
ever, the study by Kim et al. was compared with the ISKDC
project, i.e., a comparison of two different populations. One
major benefit of our study is that it is based on the compar-
ison of childhood NS within the same population. Clearly,
one question arises as to the reason for the increasing
incidence of steroid resistance in childhood NS. Kim et al.
suggested that this might be due to the high proportion of
African–Americans in their study; however, our study
shows the same development within a homogeneous popu-
lation of Caucasian children. Another hypothesis is that the
increasing incidence of steroid resistance in NS might result
from changes in the histopathology of NS toward the higher
incidence of FSGS. FSGS is a histopathological diagnosis
widely identified with the steroid-resistant model of re-
sponse in NS.
In our study some dynamic trends in the pathology of
childhood NS were also present. From kidney biopsies an
insignificant decrease in MCNS (from 25% to 9%) and
increases in MesPGN (from 46.4% to 61.3%) and FSGS
(from 17.8% to 20.4%) were observed in the most recent
decade. Unfortunately, not all steroid-resistant patients were
biopsied, mainly because of the lack of parental consent. For
comparison, in the latter period a comparable number of
biopsied steroid-resistant children showed a slight decrease
in MCNS (from 11% to 4%) and an increase in FSGS (from
22.2% to 36%) accompanied by an unchanged incidence of
MesPGN (56%). Nevertheless, none of the results describ-
ing trends in histopathology analyzed in our study reached
the level of statistical significance. Our results do not con-
tradict the observations published in recent years that show
an increasing incidence of FSGS in NS, occurring in both
children and adults [8–15, 22].
In the 1994 study by D’Agati, followed by an anal-
ysis by Haas et al. 1 year later, the researchers postu-
lated that the incidence of FSGS was rising and that
FSGS had become the most popular diagnosis of kidney
biopsies in adults with NS [9, 22]. Inspired by these
findings, in 1999 Bonilla-Felix et al. [10]p u b l i s h e d
their own results showing a significant increase (from
22% to 47%) in the incidence of FSGS in renal biopsies
performed on children with idiopathic NS over a period
of 20 years. The authors mentioned that the high pro-
portion of African–A m e r i c a n si nt h es t u d yc o u l dh a v e
influenced their results. Gulati et al. and Kari et al.
described similar trends related to the presence of FSGS
i nN Sa m o n gc h i l d r e nl i v i n gi nA s i a[ 11, 13, 15]. In
2003, Filler et al. [12] published a twofold (over a
period of 17 years) increase in the incidence of FSGS
in children, of which 89% were Caucasian. On the other
hand, in 2002, Orta-Sibu et al. [29] reported that in
Hispanic children with NS only 6.5% revealed FSGS.
Clearly, the results of the studies cited above may seem
to be inconsistent. Apparently, an ethnic composition of
the populations attending certain projects may play a
key role in the final outcome. For example, it is widely
known that African–Americans are prone to hyperten-
sion and FSGS [18–21]. Another factor that might in-
fluence results is the subjectivity of the pathologists’
assessment and poor representativeness of kidney biop-
sies. As its name suggests, FSGS is a focal lesion. As
such, it might be easily overlooked in small samples,
especially if they did not contain juxtamedullary glo-
meruli [30]. Despite the above-mentioned factors that
c o u l da f f e c tt h er e s u l t s ,s h o w i n ga ni n c r e a s ei nF S G S
in childhood NS, none of the studies proved that the
changing pattern of the histopathology of NS is the only
reason for the increase in steroid resistance of childhood
NS. The explanation for the phenomenon of increasing
frequencies of steroid-resistant patients with childhood
NS may be more complex, and probably includes the
influence of environmental and genetic factors through-
out the course of illness. Some childhood steroid-resistant
nephrotic syndromes may be due to genetically determined
syndromes with late onset, and only molecular screening
could allow these patients to be distinguished and prevented
from receiving any ineffective therapy [31, 32]. Perhaps the
results of our study reveal local trends; however, they indicate
that steroid-resistant childhood NS is becoming a growing
challenge for both doctors and patients.
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